491 related articles for article (PubMed ID: 8977430)
1. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice.
Collins S; Daniel KW; Petro AE; Surwit RS
Endocrinology; 1997 Jan; 138(1):405-13. PubMed ID: 8977430
[TBL] [Abstract][Full Text] [Related]
2. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
[TBL] [Abstract][Full Text] [Related]
3. Adaptive changes in adipocyte gene expression differ in AKR/J and SWR/J mice during diet-induced obesity.
Prpic V; Watson PM; Frampton IC; Sabol MA; Jezek GE; Gettys TW
J Nutr; 2002 Nov; 132(11):3325-32. PubMed ID: 12421846
[TBL] [Abstract][Full Text] [Related]
4. Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist.
Nagase I; Yoshida T; Kumamoto K; Umekawa T; Sakane N; Nikami H; Kawada T; Saito M
J Clin Invest; 1996 Jun; 97(12):2898-904. PubMed ID: 8675704
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines.
Rohlfs EM; Daniel KW; Premont RT; Kozak LP; Collins S
J Biol Chem; 1995 May; 270(18):10723-32. PubMed ID: 7738011
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity.
Watson PM; Commins SP; Beiler RJ; Hatcher HC; Gettys TW
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E356-65. PubMed ID: 10913036
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic manipulation of ob expression in a dietary model of obesity.
Collins S; Surwit RS
J Biol Chem; 1996 Apr; 271(16):9437-40. PubMed ID: 8621612
[TBL] [Abstract][Full Text] [Related]
8. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia.
Hamann A; Flier JS; Lowell BB
Endocrinology; 1996 Jan; 137(1):21-9. PubMed ID: 8536614
[TBL] [Abstract][Full Text] [Related]
9. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
Umekawa T; Yoshida T; Sakane N; Saito M; Kumamoto K; Kondo M
Eur J Endocrinol; 1997 Apr; 136(4):429-37. PubMed ID: 9150705
[TBL] [Abstract][Full Text] [Related]
10. Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity.
White CL; Ishihara Y; Dotson TL; Hughes DA; Bray GA; York DA
Physiol Behav; 2004 Sep; 82(2-3):489-96. PubMed ID: 15276814
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of mouse uncoupling proteins among brown adipose tissue, white adipose tissue, and skeletal muscle in chronic beta 3 adrenergic receptor agonist treatment.
Yoshitomi H; Yamazaki K; Abe S; Tanaka I
Biochem Biophys Res Commun; 1998 Dec; 253(1):85-91. PubMed ID: 9875224
[TBL] [Abstract][Full Text] [Related]
12. Beta3-adrenergic regulation of leptin, food intake, and adiposity is impaired with age.
Kumar MV; Moore RL; Scarpace PJ
Pflugers Arch; 1999 Oct; 438(5):681-8. PubMed ID: 10555566
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist.
Ghorbani M; Claus TH; Himms-Hagen J
Biochem Pharmacol; 1997 Jul; 54(1):121-31. PubMed ID: 9296358
[TBL] [Abstract][Full Text] [Related]
14. Evidence for numerous brown adipocytes lacking functional beta 3-adrenoceptors in fat pads from nonhuman primates.
Viguerie-Bascands N; Bousquet-Mélou A; Galitzky J; Larrouy D; Ricquier D; Berlan M; Casteilla L
J Clin Endocrinol Metab; 1996 Jan; 81(1):368-75. PubMed ID: 8550779
[TBL] [Abstract][Full Text] [Related]
15. Depressed expression of adipocyte beta-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents.
Collins S; Daniel KW; Rohlfs EM
Int J Obes Relat Metab Disord; 1999 Jul; 23(7):669-77. PubMed ID: 10454099
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta3-adrenergic agonist.
Margareto J; Larrarte E; Marti A; Martinez JA
Biochem Pharmacol; 2001 Jun; 61(12):1471-8. PubMed ID: 11377376
[TBL] [Abstract][Full Text] [Related]
17. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
18. Anti-obesity effects of selective agonists to the beta 3-adrenergic receptor in dogs. II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a beta 3-adrenergic agonist.
Sasaki N; Uchida E; Niiyama M; Yoshida T; Saito M
J Vet Med Sci; 1998 Apr; 60(4):465-9. PubMed ID: 9592719
[TBL] [Abstract][Full Text] [Related]
19. Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse.
Nakamura Y; Nagase I; Asano A; Sasaki N; Yoshida T; Umekawa T; Sakane N; Saito M
J Vet Med Sci; 2001 Mar; 63(3):309-14. PubMed ID: 11307932
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT monitoring of β3 agonist-stimulated brown adipocyte recruitment in white adipose tissue.
Park JW; Jung KH; Lee JH; Quach CH; Moon SH; Cho YS; Lee KH
J Nucl Med; 2015 Jan; 56(1):153-8. PubMed ID: 25525187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
